CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($) shares in Thousands, $ in Millions | Total | Cumulative Effect, Period of Adoption, Adjustment | Redeemable Non-Controlling Interests | Common Stock | Additional Paid-In Capital | Additional Paid-In CapitalCumulative Effect, Period of Adoption, Adjustment | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Non-Redeemable Non-Controlling Interests |
Beginning Balance at Dec. 31, 2019 | | | $ 311 | | | | | | |
Redeemable Non-Controlling Interests | | | | | | | | | |
Distributions to non-controlling interests | | | (3) | | | | | | |
Net income (loss) | | | (18) | | | | | | |
Ending Balance at Mar. 31, 2020 | | | 290 | | | | | | |
Beginning balance (in shares) at Dec. 31, 2019 | | | | 1,716,681 | | | | | |
Beginning balance at Dec. 31, 2019 | $ 14,872 | | | $ 0 | $ 30,739 | | $ (187) | $ (16,362) | $ 682 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 4,359 | | | | | |
Exercise of stock options | 14 | | | | 14 | | | | |
Stock-based compensation | 285 | | | | 285 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 8,917 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (107) | | | | | |
Shares withheld related to net share settlement | (3) | | | | (3) | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | (60) | | | | | | (60) | | |
Foreign currency translation adjustment | (148) | | | | | | (148) | | |
Distributions to non-controlling interests | (4) | | | | | | | | (4) |
Net income (loss) | (2,928) | | | | | | | (2,936) | 8 |
Ending balance (in shares) at Mar. 31, 2020 | | | | 1,729,850 | | | | | |
Ending balance at Mar. 31, 2020 | 12,028 | | | $ 0 | 31,035 | | (395) | (19,298) | 686 |
Beginning Balance at Dec. 31, 2019 | | | 311 | | | | | | |
Ending Balance at Sep. 30, 2020 | | | 549 | | | | | | |
Beginning balance (in shares) at Dec. 31, 2019 | | | | 1,716,681 | | | | | |
Beginning balance at Dec. 31, 2019 | 14,872 | | | $ 0 | 30,739 | | (187) | (16,362) | 682 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 10 | | | | | | | | |
Foreign currency translation adjustment | (268) | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2020 | | | | 1,760,817 | | | | | |
Ending balance at Sep. 30, 2020 | 9,633 | | | $ 0 | 31,549 | | (445) | (22,162) | 691 |
Beginning Balance at Dec. 31, 2019 | | | 311 | | | | | | |
Ending Balance at Dec. 31, 2020 | | | 787 | | | | | | |
Beginning balance (in shares) at Dec. 31, 2019 | | | | 1,716,681 | | | | | |
Beginning balance at Dec. 31, 2019 | $ 14,872 | | | $ 0 | 30,739 | | (187) | (16,362) | 682 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Accounting Standards Update [Extensible List] | Accounting Standards Update 2020-06 [Member] | | | | | | | | |
Ending balance (in shares) at Dec. 31, 2020 | 1,849,794 | | | 1,849,794 | | | | | |
Ending balance at Dec. 31, 2020 | $ 12,967 | $ (243) | | $ 0 | 35,931 | $ (243) | (535) | (23,130) | 701 |
Beginning Balance at Mar. 31, 2020 | | | 290 | | | | | | |
Redeemable Non-Controlling Interests | | | | | | | | | |
Distributions to non-controlling interests | | | (3) | | | | | | |
Net income (loss) | | | (5) | | | | | | |
Ending Balance at Jun. 30, 2020 | | | 282 | | | | | | |
Beginning balance (in shares) at Mar. 31, 2020 | | | | 1,729,850 | | | | | |
Beginning balance at Mar. 31, 2020 | 12,028 | | | $ 0 | 31,035 | | (395) | (19,298) | 686 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 3,106 | | | | | |
Exercise of stock options | 8 | | | | 8 | | | | |
Stock-based compensation | 143 | | | | 143 | | | | |
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | | | | 3,265 | | | | | |
Issuance of common stock under the Employee Stock Purchase Plan | 82 | | | | 82 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 9,778 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (42) | | | | | |
Shares withheld related to net share settlement | (1) | | | | (1) | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 8 | | | | | | 8 | | |
Foreign currency translation adjustment | (257) | | | | | | (257) | | |
Distributions to non-controlling interests | (5) | | | | | | | | (5) |
Net income (loss) | (1,767) | | | | | | | (1,775) | 8 |
Ending balance (in shares) at Jun. 30, 2020 | | | | 1,745,957 | | | | | |
Ending balance at Jun. 30, 2020 | 10,239 | | | $ 0 | 31,267 | | (644) | (21,073) | 689 |
Redeemable Non-Controlling Interests | | | | | | | | | |
Recognition of non-controlling interest upon acquisition | | | 290 | | | | | | |
Distributions to non-controlling interests | | | (1) | | | | | | |
Net income (loss) | | | (22) | | | | | | |
Ending Balance at Sep. 30, 2020 | | | 549 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 1,430 | | | | | |
Exercise of stock options | 6 | | | | 6 | | | | |
Stock-based compensation | 191 | | | | 191 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 10,791 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (356) | | | | | |
Shares withheld related to net share settlement | (11) | | | | (11) | | | | |
Issuance of common stock as consideration for acquisitions (in shares) | | | | 2,995 | | | | | |
Issuance of common stock as consideration for acquisition | 96 | | | | 96 | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 62 | | | | | | 62 | | |
Foreign currency translation adjustment | 137 | | | | | | 137 | | |
Distributions to non-controlling interests | (1) | | | | | | | | (1) |
Net income (loss) | (1,086) | | | | | | | (1,089) | 3 |
Ending balance (in shares) at Sep. 30, 2020 | | | | 1,760,817 | | | | | |
Ending balance at Sep. 30, 2020 | $ 9,633 | | | $ 0 | 31,549 | | (445) | (22,162) | 691 |
Beginning Balance at Dec. 31, 2020 | | | 787 | | | | | | |
Redeemable Non-Controlling Interests | | | | | | | | | |
Recognition of non-controlling interest upon acquisition | | | 56 | | | | | | |
Distributions to non-controlling interests | | | (356) | | | | | | |
Net income (loss) | | | (14) | | | | | | |
Ending Balance at Mar. 31, 2021 | | | 473 | | | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | 1,849,794 | | | 1,849,794 | | | | | |
Beginning balance at Dec. 31, 2020 | $ 12,967 | (243) | | $ 0 | 35,931 | (243) | (535) | (23,130) | 701 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 3,518 | | | | | |
Exercise of stock options | 35 | | | | 35 | | | | |
Stock-based compensation | 287 | | | | 287 | | | | |
Issuance of common stock for settlement of Careem Convertible Notes (in shares) | | | | 2,872 | | | | | |
Issuance of common stock for settlement of Careem Convertible Notes | 158 | | | | 158 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 10,924 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (244) | | | | | |
Shares withheld related to net share settlement | (14) | | | | (14) | | | | |
Derecognition of non-controlling interests upon divestiture | (701) | | | | | | | | (701) |
Issuance of common stock as consideration for acquisitions (in shares) | | | | 505 | | | | | |
Issuance of common stock as consideration for acquisition | 28 | | | | 28 | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 1,156 | | | | | | 1,156 | | |
Foreign currency translation adjustment | 33 | | | | | | 33 | | |
Net income (loss) | (108) | | | | | | | (108) | |
Ending balance (in shares) at Mar. 31, 2021 | | | | 1,867,369 | | | | | |
Ending balance at Mar. 31, 2021 | $ 13,598 | | | $ 0 | 36,182 | | 654 | (23,238) | 0 |
Beginning Balance at Dec. 31, 2020 | | | 787 | | | | | | |
Ending Balance at Sep. 30, 2021 | | | 229 | | | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | 1,849,794 | | | 1,849,794 | | | | | |
Beginning balance at Dec. 31, 2020 | $ 12,967 | $ (243) | | $ 0 | 35,931 | $ (243) | (535) | (23,130) | 701 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 1,625 | | | | | | | | |
Foreign currency translation adjustment | $ 78 | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | 1,918,591 | | | 1,918,591 | | | | | |
Ending balance at Sep. 30, 2021 | $ 14,056 | | | $ 0 | 37,281 | | 1,168 | (24,518) | 125 |
Beginning Balance at Mar. 31, 2021 | | | 473 | | | | | | |
Redeemable Non-Controlling Interests | | | | | | | | | |
Recognition of non-controlling interest upon acquisition | | | 76 | | | | | | |
Re-measurement of non-controlling interest | (1,058) | | 1,052 | | (1,058) | | | | |
Net income (loss) | | | (32) | | | | | | |
Ending Balance at Jun. 30, 2021 | | | 1,569 | | | | | | |
Beginning balance (in shares) at Mar. 31, 2021 | | | | 1,867,369 | | | | | |
Beginning balance at Mar. 31, 2021 | 13,598 | | | $ 0 | 36,182 | | 654 | (23,238) | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 2,454 | | | | | |
Exercise of stock options | 40 | | | | 40 | | | | |
Stock-based compensation | 282 | | | | 282 | | | | |
Reclassification of share-based award liability to additional paid-in capital | 4 | | | | 4 | | | | |
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | | | | 1,710 | | | | | |
Issuance of common stock under the Employee Stock Purchase Plan | 67 | | | | 67 | | | | |
Issuance of common stock for settlement of Careem Convertible Notes (in shares) | | | | 1,352 | | | | | |
Issuance of common stock for settlement of Careem Convertible Notes | 74 | | | | 74 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 7,480 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (55) | | | | | |
Shares withheld related to net share settlement | (3) | | | | (3) | | | | |
Re-measurement of non-controlling interest | (1,058) | | 1,052 | | (1,058) | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 6 | | | | | | 6 | | |
Foreign currency translation adjustment | 21 | | | | | | 21 | | |
Net income (loss) | 1,144 | | | | | | | 1,144 | |
Ending balance (in shares) at Jun. 30, 2021 | | | | 1,880,310 | | | | | |
Ending balance at Jun. 30, 2021 | 14,175 | | | $ 0 | 35,588 | | 681 | (22,094) | 0 |
Redeemable Non-Controlling Interests | | | | | | | | | |
Acquisition of non-controlling interest | | | (1,327) | | | | | | |
Net income (loss) | | | (13) | | | | | | |
Ending Balance at Sep. 30, 2021 | | | $ 229 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Exercise of stock options (in shares) | | | | 2,088 | | | | | |
Exercise of stock options | 17 | | | | 17 | | | | |
Stock-based compensation | 292 | | | | 292 | | | | |
Issuance of common stock for settlement of RSUs (in shares) | | | | 9,696 | | | | | |
Shares withheld related to net share settlement (in shares) | | | | (149) | | | | | |
Shares withheld related to net share settlement | $ (6) | | | | (6) | | | | |
Issuance of common stock for settlement of contingent consideration liability (in shares) | 1,364 | | | | | | | | |
Issuance of common stock for settlement of contingent consideration liability | $ 63 | | | | 63 | | | | |
Issuance of restricted stock awards, subject to repurchase, in connection with acquisition of non-controlling interest (in shares) | | | | 4,641 | | | | | |
Recognition of non-controlling interest upon sale of Freight Holding preferred stock | 125 | | | | | | | | 125 |
Issuance of common stock as consideration for acquisitions (in shares) | | | | 20,641 | | | | | |
Issuance of common stock as consideration for acquisition | 1,327 | | | | 1,327 | | | | |
Unrealized gain on investments in available-for-sale securities, net of tax | 463 | | | | | | 463 | | |
Foreign currency translation adjustment | 24 | | | | | | 24 | | |
Net income (loss) | $ (2,424) | | | | | | | (2,424) | 0 |
Ending balance (in shares) at Sep. 30, 2021 | 1,918,591 | | | 1,918,591 | | | | | |
Ending balance at Sep. 30, 2021 | $ 14,056 | | | $ 0 | $ 37,281 | | $ 1,168 | $ (24,518) | $ 125 |